TY - CHAP M1 - Book, Section TI - Rheumatoid Arthritis MTM Data Set A1 - Li, Robin Moorman A1 - Smith, Kathryn J. A2 - Whalen, Karen A2 - Hardin, Heather C. PY - 2018 T2 - Medication Therapy Management: A Comprehensive Approach, 2e AB - KEY POINTSRheumatoid arthritis (RA) is a chronic, systemic, inflammatory disease that requires early detection and proper treatment to prevent permanent joint damage.Pharmacologic therapy must be utilized in patients with RA however, including nonpharmacological options in the treatment plan can lead to improved quality of life.Although traditional nonbiologic disease-modifying antirheumatic drugs remain in use, biologic agents are gaining popularity, and new agents are in development.Serious adverse effects can occur with both the nonbiologic and the biologic disease-modifying antirheumatic drugs. Medication therapy management (MTM) providers can play a key role in proper education and routine monitoring of patients taking these medications. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1150202059 ER -